biomedicina slovenica


"Hypercholesterolemia" : 209

  1. Marčun-Varda Nataša; Nikolić Sara; Močnik Mirjam
    Subendocardial viability ratio and ejection duration as parameters of early cardiovascular risk in children
    2017
  2. Anžič Ajda; Grošelj Urh; Skarlovnik Ajda
    Ocenjevanje tveganja za srčno-žilna obolenja pri osebah z družinsko hiperholesterolemijo
    [Cardiovascular risk assessment in individuals with familial hypercholesterolemia]
    2017
  3. Marazzi Giuseppe; Pelliccia Francesco; Campolongo Giuseppe; Cacciotti Luca; Poggi Sara; Tanzilli Alessandra; Di Iorio Martina; Volterrani Maurizio; Lainščak Mitja; Rosano Giuseppe M.
    Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial
    2016
  4. Klančar Gašper; Battelino Tadej; Trebušak Podkrajšek Katarina
    Genetske značilnosti hiperholesterolemij pri otrocih in mladostnikih v Sloveniji
    [Genetic charateristics of hypercholesterolemia in children and adolescents in Slovenia]
    2016
  5. Atanasijević-Kunc Maja; Drinovec Jože; Ručigaj Simona; Mrhar Aleš
    Matematični model vpliva bolezni in dejavnikov tveganja na razvoj možganske kapi
    2007
  6. Mičetić-Turk Dušanka; Šikić Pogačar Maja; Marčun-Varda Nataša; Dolinšek Jernej; Urlep Žužej Darja
    The impact of overweight and obesity on health-related quality-of-life among children and adolescents in Slovenia
    2008
  7. Obesity, familial hypercholesterolemia
    2008
  8. Klančar Gašper; Grošelj Urh; Kovač Jernej; Bratanič Nevenka; Bratina Nataša; Battelino Tadej; Trebušak Podkrajšek Katarina
    Implementation of next generation sequencing in national universal hypercholesterolemia screening
    2015
  9. Klančar Gašper; Grošelj Urh; Kovač Jernej; Bratanič Nevenka; Bratina Nataša; Trebušak Podkrajšek Katarina; Battelino Tadej
    Universal screening for familial hypercholesterolemia in children
    2015
  10. Klančar Gašper; Trebušak Podkrajšek Katarina
    Opredelitev genskih vzrokov hiperholesterolemij
    [Determination of genetic causes of hypercholesterolemia]
    2014
  11. Klančar Gašper; Grošelj Urh; Bratina Nataša; Bratanič Nevenka; Battelino Tadej; Trebušak Podkrajšek Katarina
    The LDLR gene analysis in the slovene familial hypercholesterolemia (fh) population
    2012
  12. Grošelj Urh; Klančar Gašper; Bratina Nataša; Bratanič Nevenka; Trebušak Podkrajšek Katarina; Battelino Tadej
    Some characteristics of the Slovene familial hypercholesterolemia (FH) pediatric population
    2012
  13. Kovač Urša; Košir Rok; Fužir Natalija; Lewinska Monika; Kovač Jernej; Klančar Gašper; Trebušak Podkrajšek Katarina; Kotnik Primož; Battelino Tadej; Rozman Damjana
    PNPLA3 as a potential marker for non-alcoholic fatty liver disease in children with familial hypercholesterolemia?
    2015
  14. Klančar Gašper; Grošelj Urh; Bratina Nataša; Trebušak Podkrajšek Katarina; Battelino Tadej
    LDLR and APOB gene analysis in the Slovene population of the children and adolescents with hypercholesteromia
    2013
  15. Klančar Gašper; Malovrh Petra; Grošelj Urh; Bratanič Nevenka; Bratina Nataša; Božič Mojca; Cevc Matija; Battelino Tadej; Trebušak Podkrajšek Katarina
    Familial defective apolipoprotein B-100
    2014
  16. Klančar Gašper; Grošelj Urh; Bratina Nataša; Bratanič Nevenka; Trebušak Podkrajšek Katarina; Battelino Tadej
    Genetic characteristics of hypercholesterolemia in children and adolescents in Slovenia
    2013
  17. Grošelj Urh; Klančar Gašper; Bratina Nataša; Bratanič Nevenka; Trebušak Podkrajšek Katarina; Battelino Tadej
    Clinical and genetic characteristics of the paediatric heterozygous familial hypercholesterolaemia population in Slovenia: a preliminary report
    2013
  18. Ponikvar Rafael; Žugić Ratko; Dedić Hasan; Gaber Liljana; Buturović-Ponikvar Jadranka; Kovač Janko; Premru Vladimir; Benedik Miha; Marn-Pernat Andreja; Gubenšek Jakob; Poljančič A; Knap Bojan
    22 years of LDL apheresis in a patient with familial homozigous hypercholesterolemia
    2012
  19. Kusters DM; de Beaufort C; Widhalm K; Guardamagna O; Bratina N; Ose L; Wiegman A
    Paediatric screening for hypercholesterolaemia in Europe
    2012
  20. Poredoš Pavel; Ježovnik Mateja Kaja
    Dyslipidemia, statins, and venous thromboembolism
    2011
  21. Režen Tadeja
    The impact of cholesterol and its metabolites on drug metabolism
    2011
  22. Lunder Mojca; Žiberna Lovro; Drevenšek Gorazd; Šabovič Mišo
    Zaščitni pleiotropni učinki statinov
    [Beneficial pleiotropic effects of statins]
    2011
  23. Tušek-Bunc Ksenija; Kersnik Janko; Petek-Šter Marija; Petek Davorina; Klemenc-Ketiš Zalika
    Explanatory model of prescribing behavior in prescription of statins in family practice
    2010
  24. Pietroleonardo L; Ruzicka T
    Skin manifestations in familial heterozygous hypercholesterolemia
    2009
  25. Premru V; Ponikvar R
    LDL apheresis in two children with homozygous familiar hypercholesterolemia
    2009
  26. Bregar U; Poredoš P; Šabovič M; Jug B; Šebeštjen M
    The influence of atorvastatin on walking performance in peripheral arterial disease
    2009
  27. Kuzman Drago; Fon Tacer Klementina; Černe M; Režen Tadeja; Ačimovič Jure; Čegovnik Urška; Kocjan Darko; Urleb Uroš; Rozman Damjana
    Modulation of hepatic transcriptomein the poloxamer P-407 hyperlipidemia mouse model
    2009
  28. Bregar Urška
    Hemodinamski učinki statinov pri bolnikih s periferno arterijsko boleznijo: magistrsko delo
    2008
  29. Premru V; Ponikvar R
    LDL apheresis in two children with homozygous familiar hypercholesterolemia
    2008
  30. Atanasijević-Kunc Maja; Drinovec Jože; Ručigaj Simona; Mrhar Aleš
    Modelling of the risk factors and chronic diseases that influence the development of serious health complications
    [Modeliranje dejavnikov tveganja in kroničnih bolezni, ki vplivajo na razvoj hujših zdravstvenih zapletov]
    2008
  31. Barbič-Žagar Breda; Kos Jernej; Grošelj Mateja
    Klinične izkušnje z atorvastatinom v visokih odmerkih
    [Clinical experience with high doses of atorvastatin]
    2007
  32. Kohalmy Krisztina; Rozman Damjana; Pascussi Jean-Marc; Sarvary Eniko; Monostory Katalin
    A koleszterinhomeosztazis es a gyogyszer-metabolizmus kapcsolata
    [Crosstalk between cholesterol homeostasis and drug metabolism]
    2008
  33. Pregelj Peter
    Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins
    2008
  34. Vrtovec B; Okrajšek R; Goličnik A; Ferjan M; Starc V; Schlegel TT; Radovancevic B
    Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure
    2008
  35. Poredoš P
    Secondary prevention of peripheral arterial disease with drugs
    2007
  36. Nicholls Stephen J; Tuzcu E Murat; Sipahi Ilke; Grasso Adam W; Schoenhagen Paul; Hu Tingfei; Wolski Kathy; Crowe Tim; Desai Milind Y; Hazen Stanley L
    Statini, holesterol v lipoproteinih velike gostote in regresija koronarne ateroskleroze
    [Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis]
    2007
  37. Fras Zlatko
    Je mogoče s statini zavreti ali celo (o)zdraviti aterosklerozo?
    2007
  38. Kenda Miran F.; Fras Zlatko
    25. Radenski dnevi. Program in zbornik prispevkov: jubilejno tradicionalno letno strokovno srečanje Združenja kardiologov Slovenije; 2007 maj 24-26; Radenci
    2007
  39. Lainščak Mitja; von Haehling Stephan; Springer Jochen; Anker Stefan D
    Biomarkers for chronic heart failure
    2007
  40. Fras Zlatko
    Preventivni ukrepi in zdravljenje dislipidemij pri bolniku po prebolelem srčnem infarktu
    2007
  41. Bulc Mateja
    Why men?
    2001
  42. Bedernjak-Bajuk Nataša
    Sladkorna bolezen - tveganje za nastanek akutnega infarkta srca
    2000
  43. Žemva Aleš; Benca Maja
    From endothelial dysfunction to hypertension
    [Od endotelijske disfunkcije do hipertenzije]
    2006
  44. Gomez MI; Perez B; Contreras JA; de Las Heras MH; Rocamora A; Ledo A
    Xanthoma disseminatum associated with hypocholesterolemia and hypolipoproteinemia
    1994
  45. Del Rio M; Chulia T; Merchan-Perez A; Remezal M; Valor S; Gonzalez J; Gutierrez JA; Contreras JA; Lasuncion MA; Tejerina T
    Effects of indapamide on atherosclerosis development in cholesterol-fed rabbits
    1995
  46. Eržen Barbara; Gradišek Primož; Poredoš Pavel; Šabovič Mišo
    Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries
    2006
  47. Dajčman Davorin
    Bolnik z mešano hiperlipidemijo, periferno okluzivno arterijsko boleznijo in prsno bolečino - prikaz primera
    [Patient with mixed hyperlipidemia, peripheral occlusive arterial disease and chest pain - case report]
    2006
  48. Završnik Matej
    Motnje v presnovi maščob
    [Dyslipidemia]
    2006
  49. Lainščak Mitja; Fras Zlatko
    Ali je nefarmakološka obravnava hiperholesterolemije lahko učinkovita? Rezultati raziskave Becel Pro.Activ v Sloveniji
    2006
  50. Cevc Matija
    Farmakoekonomika zdravljenja dislipedemij pri bolnikih z akutnim koronarnim sindromom
    [Pharmacoeconomics of dyslipidemia treatment in patients with acute coronary syndrome]
    2006
  51. Fras Zlatko
    Učinkovitost kombiniranega zdravljenja hiperholesterolemije s statini in ezetimibom - prikaz rezultatov raziskave SI-SPECT
    [Effectiveness of combined statin plus ezetimibe treatment of hypercholesterolemia - presentation of SI-SPECT programme results]
    2006
  52. Lainščak Mitja; Fras Zlatko
    Nefarmakološki ukrepi ob hiperholesterolemiji - ali imamo nove možnosti?
    2006
  53. Šabovič Mišo
    Zdravljenje stabilne angine pektoris s statini
    2006
  54. Binbrek Azan S; Elis Avishay; Al-Zaibag Muayed; Eha Jaan; Keber Irena; Cuevas Ada M; Mukherjee Swati; Miller Thomas R
    Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: a randomized, open-label, parallel-group, multicenter study (DISCOVERY alpha study)
    2006
  55. Fras Zlatko
    Kako obravnavamo dislipidemije v Sloveniji?
    2006
  56. Cevc Matija
    Farmakoekonomske osnove zdravljenja dislipidemij
    2006
  57. Černe Andreja
    Maščobe v krvi
    2005
  58. Fras Zlatko
    Obravnava dislipidemije pri metaboličnem sindromu
    2005
  59. Bešlić Šerif; Dalagija Faruk
    Coronary artery calcium scoring in myocardial infarction
    [Ugotavljanje koronarne kalcifikacije pri miokardnem infarktu]
    2005
  60. Štubler Mira
    Zdravstvena nega po operaciji in svetovanje glede zdravega načina življenja
    2005
  61. Černe Andreja; Kranjec Igor; Peterlin Borut
    Angiotensin-converting enzyme gene polymorphism and acute coronary syndrome
    [Polimorfizmi gena za encim angiotenzinsko konvertazo pri bolnikih z akutnim koronarnim sindromom]
    2005
  62. Medvešček Marko
    Sladkorna bolezen tipa 2 - pandemija 21. stoletja
    2004
  63. Tasič Janez
    Zniževanje holesterola - dieta namesto zdravil!
    2003
  64. Hlastan-Ribič Cirila
    Tudi rastlinske maščobe so lahko škodljive
    2003
  65. Uršič-Bratina Nataša; Bratanič Nina; Battelino Tadej
    Nevarne povišane maščobe v krvi otroka
    2003
  66. Blinc Aleš
    Sistematično izmišljanje novih bolezni?
    2003
  67. Bombek Mirko
    Koliko smo naredili za preprečevanje bolezni srca in ožilja?
    2002
  68. Pavčič Maruša
    S fitosteroli nad holesterol
    2001
  69. Cevc Matija
    Povišana raven holesterola v krvi v poznejših letih
    2005
  70. Bratanič Nevenka; Vesel Samo; Uršič-Bratina Nataša; Žerjav-Tanšek Mojca; Sedmak Marjeta; Kržišnik Ciril; Battelino Tadej
    Familiarna hiperholesterolemija
    2005
  71. Šebeštjen Miran
    Novi dejavniki tveganja za aterosklerozo: pomen in možnosti zdravljenja
    2005
  72. Pintar Tatjana
    Vpliv statinov na pooperativne zaplete pri bolnikih po kirurški revaskularizaciji venčnih arterij
    2005
  73. Grad Anton; Žvan Bojana
    Možganska kap v Sloveniji upada
    2001
  74. Rotovnik-Kozjek Nada
    Prehrana, gibanje in zdravje
    2005
  75. Zaletel-Kragelj Lijana; Fras Zlatko
    Stanje gibanja za zdravje pri odraslih prebivalcih v Sloveniji. Rezultati skupne raziskave CINDI Slovenije in projekta CRP Gibalna/športna aktivnost za zdravje
    2005
  76. Goličnik Alenka; Ferjan Mateja
    Vpliv atorvastatina na trajanje intervala QTC pri bolnikih s srčnim popuščanjem
    2004
  77. Tomažič Janez; Silič Anja; Karner Primož; Vidmar Ludvik; Matičič Mojca; Poljak Mario; Ihan Alojz; Janež Andrej
    Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients
    2004
  78. Poredoš Pavel
    Involvement of endothelial dysfunction in atherogenesis
    2004
  79. Poredoš Pavel; Blinc Aleš
    What is new in angiology?
    2005
  80. Strasser Thomas
    Epidemiologija hipertenzije
    2004
  81. Dolenc Ester
    Razširjenost dejavnikov tveganja za kronične nenalezljive bolezni v vzorcu odraslih oskrbovancev Splošne ambulante Miren-Kostanjevica na Krasu v letu 2002
    2004
  82. Poredoš Pavel
    Periferna arterijska bolezen in hiperlipidemija
    [Peripheral artery disease and dyslipidemia]
    2004
  83. Žvan Bojana; Zaletel Marjan
    Možganskožilne bolezni pri ženskah
    2004
  84. Barbič-Žagar Breda
    Učinkovitost in varnost Vasilipa pri bolnikih s hiperholesterolemijo
    [The efficacy and safety of Vasilip in patients with hypercholesterolemia]
    2002
  85. Reiner Željko; Tedeschi-Reiner Eugenia
    Vloga statinov v preprečevanju srčno-žilnih bolezni
    [The role of statins in the prevention of cardiovascular diseases]
    2002
  86. Barbič-Žagar Breda; Drinovec Jože
    Predgovor
    2002
  87. Marušič Andrej
    Osebnostni profil in izpostavljenost stresu pri koronarografiranih bolnikih z angino pektoris
    1992
  88. Vrečer M; Turk S; Drinovec J; Mrhar A
    Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke: meta-analysis of randomized trials
    2003
  89. Eržen Barbara
    Endotelijska disfunkcija pri mladih moških po prebolelem srčnem infarktu
    2003
  90. Uršič-Bratina Nataša; Bratanič Nina; Žerjav-Tanšek Mojca; Kržišnik Ciril; Battelino Tadej
    The results of the screening for hypercholesterolemia in 5 year old children in Slovenia
    2002
  91. Oguchi S; Dimayuga P; Chyu K-Y; Zhu J; Shah PK; Nilsson J; Čerček B
    VCAM-1 regulation after arterial wall injury
    2000
  92. Naqvi T; Shah PK; Ivey PA; Molloy MD; Thomas AM; Panicker S; Ahmed A; Čerček B; Kaul S
    Evidence that HDL is an independent predictor of acute platelet-dependent thrombus formation
    1999
  93. Dimayuga P; Zhu J; Oguchi S; Chyu KY; Yano J; Shah PK; Nilsson J; Čerček B
    Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff induced carotid injury in apoE null mice
    1999
  94. Nilsson J; Calara R; Regnstrom JR; Hultgardh-Nilsson A; Ameli S; Čerček B; Shah PK
    Immunization with homologous oxidized low density lipoprotein reduces neointima formation following balloon-injury in hypercholesterolemic rabbits
    1997
  95. Ameli S; Hultgardh-Nilsoon A; Regnstrom J; Calara F; Čerček B; Shah PK; Nilsson J
    Effect of immunization with homologous unmodified and oxidized low density lipoprotein on early atherosclerosis in hypercholesterolemic rabbits
    1996
  96. Ameli S; Hultgardh-Nilsson A; Čerček B; Shah PK; Forrester JS; Ageland H; Nilsson J
    Recombinant apolipoprotein A-I Milano reduces intimal thickening following balloon-injury in hypercholesterolemic rabbits
    1994
  97. Dugonik A; Belič M; Miljković J
    Eosinophilic fasciitis
    2003
  98. Eidelman Rachel S; Lamas Gervasio A; Hennekens Charles H
    Nov državni program za izobraževanje o holesterolu: klinični izziv za bolj razširjeno uveljavitev protilipidnega zdravljenja in preprečevanja koronarne srčne bolezni
    [The new national cholesterol education program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease]
    2003
  99. Osredkar Joško
    Stopenjska laboratorijska diagnostika kardiovaskularnih bolezni
    [Stes in laboratory diagnostic of cardiovascular diseases]
    2003
  100. Hojs Radovan; Hojs-Fabjan Tanja; Pečovnik-Balon Breda
    Atherosclerosis in patients with end-stage renal failure prior to initiation of hemodialysis
    2003

1 101 201  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics